(Q69047590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Specific inhibition of sarcoma-specific cellular immunity by sera from patients with growing sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4524527

30 January 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

30 January 2023

author name string

A. M. Cohen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4524527

30 January 2023

A. S. Ketcham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4524527

30 January 2023

D. L. Morton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4524527

30 January 2023

language of work or name

English

0 references

publication date

1 March 1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

15 March 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4524527

full work available at URL

30 January 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910110205

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910110205

30 January 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

International Journal of Cancer

30 January 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

273-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1

31

997

Ankerst

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Cellular and humoral immune responses to human urinary bladder carcinomas

30 January 2023

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

A microassay for cytotoxic antibody using 125 I-iododeoxyuridine-labelled target cells

30 January 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

30 January 2023

6

32

2421

Cohen

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Cellular immunity and its serum-mediated inhibition in shope-virus-induced rabbit papillomas

30 January 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Studies on cellular immunity and its serum-mediated inhibition in moloney-virus-induced mouse sarcomas

30 January 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens

30 January 2023

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas

30 January 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Demonstration of cell-mediated immunity to human neoplasms of various histological types

30 January 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

30 January 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Studies on serum-mediated inhibition of cellular immunity to spontaneous mouse mammary tumors

30 January 2023

14

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Tumor associated antigen with pulmonary neoplasms

30 January 2023

15

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Effect of autologous tumor extracts on cultured human peripheral blood lymphocytes

30 January 2023

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation

30 January 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

30 January 2023

21

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system

30 January 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910110205

30 January 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4524527%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference